Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value:
$1.34B
Total Bought:
$120.34M
Total Sold:
$138.44M
Net Transaction:
-$18.10M
Notable People:
Bihua Chen, Cormorant Asset Management Gp,
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)8,494,1518,494,1510$331.87M$400.92M29.86%+$69.06M
EyePoint, Inc.(EYPT)8,325,0008,325,0000$45.12M$78.34M5.84%+$33.22M
BridgeBio Pharma, Inc.(BBIO)2,000,0001,600,000-400,000$69.14M$69.09M5.15%-$52.0K
Praxis Precision Medicines, Inc.(PRAX)1,745,0001,625,000-120,000$66.08M$68.33M5.09%+$2.25M
Merus N V740,0001,120,000+380,000$31.15M$58.91M4.39%+$27.77M
Edgewise Therapeutics, Inc.(EWTX)4,101,9924,251,992+150,000$90.24M$55.74M4.15%-$34.50M
Insmed Incorporated(INSM)525,000540,000+15,000$40.05M$54.35M4.05%+$14.29M
Arcellx Inc
COMMON STOCK
1,050,000800,000-250,000$68.88M$52.68M3.92%-$16.20M
Newamsterdam Pharma Company
ORDINARY SHARES
2,825,0002,175,000-650,000$57.83M$39.39M2.93%-$18.44M
Janux Therapeutics, Inc.(JANX)2,000,0001,500,000-500,000$54.00M$34.65M2.58%-$19.35M
Rapport Therapeutics, Inc.(RAPP)2,940,9212,940,9210$29.50M$33.44M2.49%+$3.94M
Verona Pharma PlcADS0350,000+350,000$0$33.10M2.47%+$33.10M
Helix Acquisition Corp IiCL A2,909,0002,909,0000$32.87M$30.89M2.30%-$1.98M
Bright Minds Biosciences Inc.(DRUG)1,059,3311,059,3310$38.21M$27.66M2.06%-$10.55M
Centessa Pharmaceuticals PlcADS2,261,6002,086,600-175,000$32.52M$27.42M2.04%-$5.10M
Pharvaris N V
COM
1,466,4601,454,660-11,800$23.02M$25.60M1.91%+$2.58M
GH Research PLC(GHRS)2,009,4822,009,4820$22.16M$24.50M1.82%+$2.33M
ARS Pharmaceuticals, Inc.(SPRY)1,600,0001,100,000-500,000$20.13M$19.20M1.43%-$933.0K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)2,375,0002,375,0000$12.61M$16.39M1.22%+$3.78M
ABIVAX Société AnonymeADS(ABVX)2,130,0002,130,0000$13.31M$16.29M1.21%+$2.98M
CG Oncology, Inc.(CGON)775,000625,000-150,000$18.98M$16.25M1.21%-$2.73M
Arcutis Biotherapeutics, Inc.(ARQT)1,350,0001,000,000-350,000$21.11M$14.02M1.04%-$7.09M
Cargo Therapeutics Inc3,381,2773,381,2770$13.76M$13.93M1.04%+$169.1K
Tarsus Pharmaceuticals, Inc.(TARS)400,000300,000-100,000$20.55M$12.15M0.91%-$8.39M
Crinetics Pharmaceuticals In600,000400,000-200,000$20.12M$11.50M0.86%-$8.62M
Metsera Inc400,000400,0000$10.89M$11.38M0.85%+$492.0K
Aardvark Therapeutics Inc800,189800,1890$6.01M$10.82M0.81%+$4.81M
Axsome Therapeutics, Inc.(AXSM)250,000100,000-150,000$29.16M$10.44M0.78%-$18.72M
BioAge Labs, Inc.(BIOA)2,629,5292,140,605-488,924$9.89M$8.84M0.66%-$1.05M
Engene Holdings Inc
COM
2,323,5952,323,5950$10.41M$8.46M0.63%-$1.95M
MBX Biosciences, Inc.(MBX)700,000700,0000$5.17M$7.99M0.59%+$2.82M
Cabaletta Bio, Inc.(CABA)05,000,000+5,000,000$0$7.60M0.57%+$7.60M
Alumis Inc2,147,3962,147,3960$13.19M$6.44M0.48%-$6.74M
Biomea Fusion, Inc.(BMEA)3,570,8723,570,8720$7.61M$6.43M0.48%-$1.18M
Korro Bio, Inc.(KRRO)380,303465,000+84,697$6.62M$5.81M0.43%-$813.2K
Vaxcyte, Inc.(PCVX)175,000175,0000$6.61M$5.69M0.42%-$918.8K
Avidity Biosciences Inc400,000200,000-200,000$11.81M$5.68M0.42%-$6.13M
Enliven Therapeutics Inc250,000200,000-50,000$4.92M$4.01M0.30%-$908.0K
Stoke Therapeutics, Inc.(STOK)254,161254,1610$1.69M$2.88M0.21%+$1.19M
KALA BIO, Inc.(KALA)603,027603,0270$3.46M$2.87M0.21%-$584.9K
Yarrow Bioscience Inc(YARW)01,370,938+1,370,938$0$2.26M0.17%+$2.26M
Biohaven Ltd.(BHVN)10,00010,0000$240.4K$141.1K0.01%-$99.3K
OnKure Therapeutics, Inc.CL A(OKUR)1,837,7390-1,837,739$7.90M$0—-$7.90M
Pliant Therapeutics, Inc.(PLRX)3,000,0000-3,000,000$4.05M$0—-$4.05M
Rhythm Pharmaceuticals, Inc.(RYTM)150,0000-150,000$7.95M$0—-$7.95M
Page 1 of 1